WHO Issues First Guidelines for Managing Childhood Obesity
On October 7, 2026, the World Health Organization published guidelines for managing obesity in children and adolescents, prioritizing behavioral interventions over pharmacological or surgical treatments. The new recommendations, released Thursday, advise against the use of weight-loss drugs and bariatric surgery for children aged 0 to 9 years, emphasizing instead the importance of structured diets, physical activity, and sustainable lifestyle changes.
In the United States, nearly one in five adults reported taking a GLP-1 drug at some point for diabetes or weight loss.
Treatment Recommendations by Age Group
For children under 10, the WHO explicitly states that pharmacological treatment and bariatric surgery are not recommended. The agency stresses that the foundation of care for this age group must be comprehensive support for healthy eating and physical activity. For adolescents aged 10 to 19, the guidelines offer a more nuanced approach. According to Health Policy Watch, approved medications may be considered only after supervised multimodal lifestyle programs have failed to achieve desired results. Bariatric surgery remains an option for adolescents with severe obesity, but only under strict conditions and when the patient demonstrates physical and mental maturity.
The WHO added GLP-1 medications to its recommended adult obesity guidelines in 2025 under conditional status before evaluating pediatric indications.
Research from Lurie Children's Hospital indicated GLP-1 medications in pediatric cohorts are linked to vitamin D deficiencies, with only 5% of pediatric patients receiving nutritional counseling.
Addressing Global Obesity Trends
These guidelines arrive as the prevalence of obesity among 5 to 19-year-olds has surged globally, rising from 2 percent in 1990 to 8 percent in 2024. According to WHO data, approximately 170 million children and adolescents worldwide are currently classified as obese. Luz Maria De Regil, director of the WHO's nutrition and food safety department, noted that while some high-income nations are beginning to see a plateau in obesity rates, the condition is growing rapidly in low- and middle-income countries. The WHO also highlighted the critical need to address mental health, noting that anxiety, depression, and low self-esteem are often linked to unhealthy eating behaviors and social withdrawal in children living with obesity.
The WHO guidelines evaluated findings from 35 scholarly review articles.
Dr. Laurence Grummer-Strawn, WHO unit head of Nutrition and Food Safety Action, highlighted that structural environmental factors such as junk food marketing and school diets strongly govern childhood obesity risk.
Future Monitoring and Research
The WHO acknowledged that the field of anti-obesity medication is evolving rapidly, particularly with the rise of GLP-1 agonists. While the agency previously supported GLP-1 treatments for adults in 2025, it maintains that there is currently insufficient long-term evidence regarding the safety and efficacy of these drugs for younger populations. Scientists at the agency are continuing to monitor clinical trial data as it becomes available to determine if future recommendations for younger children might change.
How to read the childhood obesity guidance
The central distinction is between supporting a child's health and prescribing aggressive weight loss. International guidelines guide policymakers and clinicians; they do not replace individual paediatric assessment or create identical requirements across health systems. Recommendations for younger children should be read alongside family circumstances, nutrition, sleep, physical activity and mental wellbeing. The WHO document specifically concerns children under ten, so conclusions about older adolescents require separate guidance. Parents should avoid turning a global policy headline into self-directed medication or surgical decisions.